Association between obstructive lung disease and markers of HIV infection in a high-risk cohort

Thorax

Volumn 67, Issue 4, 2012, Pages 309-314

  Drummond, M Bradley ^a   Kirk, Gregory D ^a,b   Astemborski, Jacquie ^b   Marshall, Mariah M ^b   Mehta, Shruti H ^b   McDyer, John F ^a   Brown, Robert H ^a   Wise, Robert A ^a   Merlo, Christian A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BACTERIAL PNEUMONIA; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY; URBAN POPULATION; VIRUS LOAD;

EID: 84858791982     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200702     Document Type: Article

References (33)

1. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9. (Pubitemid 41352114)
2. Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ 2002;51:1-13.
3. Kirk GD, Merlo CA; Lung HIV Study. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc 2011;8: 326-32.
4. Marshall MM, McCormack MC, Kirk GD. Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev 2009;21(Suppl 3):28-39.
5. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000;132:369-72. (Pubitemid 30127775)
6. Crothers K, Butt AA, Gibert CL, et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006;130:1326-33. (Pubitemid 44786723)
7. Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992;116:124-8.
8. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011;183:388-95.
9. George MP, Kannass M, Huang L, et al. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009;4:e6328.
10. Gingo MR, George MP, Kessinger CJ, et al. Pulmonary function abnormalities in HIVinfected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010;182:790-6.
11. Cui Q, Carruthers S, McIvor A, et al. Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther 2010;7:6.
12. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV- 1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75-100. (Pubitemid 23095616)
13. Drummond MB, Kirk GD, Ricketts EP, et al. Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med 2010;10:27.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. (Pubitemid 41079078)
15. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-87. (Pubitemid 29036522)
16. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. (Pubitemid 41632054)
17. Gomez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease. Curr Opin Pulm Med 2002;8:81-6. (Pubitemid 34164002)
18. Orendi JM, Bloem AC, Borleffs JC, et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998;178:1279-87. (Pubitemid 28523264)
19. Froebel KS, Raab GM, D'Alessandro C, et al. A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable. Clin Exp Immunol 2000;122:72-8.
20. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822-6.
21. Twigg HL, Soliman DM, Day RB, et al. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;159:1439-44. (Pubitemid 29227851)
22. Yearsley MM, Diaz PT, Knoell D, et al. Correlation of HIV-1 detection and histology in AIDS-associated emphysema. Diagn Mol Pathol 2005;14:48-52. (Pubitemid 40283862)
23. Matsumoto T, Miike T, Nelson RP, et al. Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol 1993;93:149-51. (Pubitemid 23238018)
24. Lahdevirta J, Maury CP, Teppo AM, et al. Elevated levels of circulating cachectin/ tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-91.
25. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-56.
26. Karadag F, Karul AB, Cildag O, et al. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008;186:403-9.
27. Motz GT, Eppert BL, Wesselkamper SC, et al. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. Am J Respir Crit Care Med 2010;181:1223-33.
28. Shirai T, Suda T, Inui N, et al. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD. Allergol Int 2010;59:75-82.
29. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest 2002;121:370-6. (Pubitemid 34132971)
30. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. (Pubitemid 38269277)
31. Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients. Chest 2003;123:596-9. (Pubitemid 36269447)
32. Kanazawa H, Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004;116:749-52. (Pubitemid 38622311)
33. Silva DR, Stifft J, Cheinquer H, et al. Prevalence of hepatitis C virus infection in patients with COPD. Epidemiol Infect 2010;138:167-73.